{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T06:43:00Z","timestamp":1791009780467,"version":"4.1.0"},"reference-count":63,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2011,10,1]],"date-time":"2011-10-01T00:00:00Z","timestamp":1317427200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2011,10]]},"DOI":"10.1016\/j.bbr.2011.04.041","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T00:37:51Z","timestamp":1304815071000},"page":"271-279","source":"Crossref","is-referenced-by-count":95,"title":["The novel \u03b4 opioid receptor agonist KNT-127 produces antidepressant-like and antinociceptive effects in mice without producing convulsions"],"prefix":"10.1016","volume":"223","author":[{"given":"Akiyoshi","family":"Saitoh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azusa","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Nemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Ichiro","family":"Oka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Nagase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2011.04.041_bib0005","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1152\/physrev.00005.2009","article-title":"Reward processing by the opioid system in the brain","volume":"89","author":"Le Merrer","year":"2009","journal-title":"Physiol Rev"},{"key":"10.1016\/j.bbr.2011.04.041_bib0010","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/(SICI)1098-2396(199609)24:1<19::AID-SYN3>3.0.CO;2-J","article-title":"Imaging of delta opioid receptors in human brain by N1\u2032-([11C]methyl)naltrindole and PET","volume":"24","author":"Madar","year":"1996","journal-title":"Synapse"},{"key":"10.1016\/j.bbr.2011.04.041_bib0015","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/76061","article-title":"Mice deficient for delta- and mu-opioid receptors exhibit opposing alterations of emotional responses","volume":"25","author":"Filliol","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.bbr.2011.04.041_bib0020","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1016\/S0893-133X(01)00413-4","article-title":"Nonpeptidic delta-opioid receptor agonists reduce immobility in the forced swim assay in rats","volume":"26","author":"Broom","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.bbr.2011.04.041_bib0025","doi-asserted-by":"crossref","first-page":"16459","DOI":"10.1523\/JNEUROSCI.3748-10.2010","article-title":"Ligand-directed trafficking of the \u03b4-opioid receptor in vivo: two paths toward analgesic tolerance","volume":"30","author":"Pradhan","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0030","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00213-005-0112-6","article-title":"Role of delta-opioid receptor subtypes in anxiety-related behaviors in the elevated plus-maze in rats","volume":"182","author":"Saitoh","year":"2005","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2011.04.041_bib0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1254\/jjp.90.1","article-title":"Behavioral effects of delta-opioid receptor agonists: potential antidepressants?","volume":"90","author":"Broom","year":"2002","journal-title":"Jpn J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1097\/00008877-200311000-00003","article-title":"Effects of the delta-opioid receptor agonist SNC80 on learning relative to its antidepressant-like effects in rats","volume":"14","author":"Jutkiewicz","year":"2003","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0045","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0163-7258(00)00099-1","article-title":"Regulations of opioid dependence by opioid receptor types","volume":"89","author":"Narita","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0050","series-title":"The delta receptor","first-page":"297","article-title":"The delta opioid receptor subtypes and pain modulation","author":"Ossipov","year":"2004"},{"key":"10.1016\/j.bbr.2011.04.041_bib0055","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.brainres.2007.07.095","article-title":"Antidepressant-like effects of the delta-opioid receptor agonist SNC80 ([(+)-4-[(alphaR)-alpha-[(2S,5R)-2,5-dimethyl-4-(2-propenyl)-1-piperazinyl]-(3-methoxyphenyl)methyl]-N,N-diethylbenzamide) in an olfactory bulbectomized rat model","volume":"1208","author":"Saitoh","year":"2008","journal-title":"Brain Res"},{"key":"10.1016\/j.bbr.2011.04.041_bib0060","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1126\/science.1335167","article-title":"Cloning of a delta opioid receptor by functional expression","volume":"258","author":"Evans","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.bbr.2011.04.041_bib0065","doi-asserted-by":"crossref","first-page":"12048","DOI":"10.1073\/pnas.89.24.12048","article-title":"The delta-opioid receptor: isolation of a cDNA by expression cloning and pharmacological characterization","volume":"89","author":"Kieffer","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2011.04.041_bib0070","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0022-3565(25)20256-7","article-title":"Lack of antinociceptive cross-tolerance between [D-Pen2, D-Pen5]enkephalin and [D-Ala2]deltorphin II in mice: evidence for delta receptor subtypes","volume":"258","author":"Mattia","year":"1991","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0075","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0024-3205(95)00256-6","article-title":"Effects of a highly selective nonpeptide delta opioid receptor agonist, TAN-67, on morphine-induced antinociception in mice","volume":"57","author":"Suzuki","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0080","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.pa.36.040196.002115","article-title":"Opioid receptor types and subtypes: the delta receptor as a model","volume":"36","author":"Zaki","year":"1996","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S0022-3565(24)36426-2","article-title":"Delta-1 opioid receptor-mediated antinociceptive properties of a nonpeptidic delta opioid receptor agonist, (\u2212)TAN-67, in the mouse spinal cord","volume":"280","author":"Tseng","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0090","series-title":"The delta receptor","first-page":"331","article-title":"Delta opioid receptor-mediated antinociception\/analgesia","author":"Narita","year":"2004"},{"key":"10.1016\/j.bbr.2011.04.041_bib0095","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1046\/j.1460-9568.2001.01363.x","article-title":"Lack of dependence and rewarding effects of deltorphin II in mu-opioid receptor-deficient mice","volume":"13","author":"Hutcheson","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0100","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1111\/j.0953-816X.2004.03339.x","article-title":"The delta agonists DPDPE and deltorphin II recruit predominantly mu receptors to produce thermal analgesia: a parallel study of mu, delta and combinatorial opioid receptor knockout mice","volume":"19","author":"Scherrer","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0105","doi-asserted-by":"crossref","first-page":"3594","DOI":"10.2741\/3474","article-title":"Modulation of opioid receptor function by protein\u2013protein interactions","volume":"14","author":"Alfaras-Melainis","year":"2009","journal-title":"Front Biosci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0110","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1248\/cpb.46.1695","article-title":"Rational drug design and synthesis of a highly selective nonpeptide delta-opioid agonist, (4aS*,12aR*)-4a-(3-hydroxyphenyl)-2-methyl-1,2,3,4,4a,5,12,12a-octahydropyrido[3,4-b]acridine (TAN-67)","volume":"46","author":"Nagase","year":"1998","journal-title":"Chem Pharm Bull (Tokyo)"},{"key":"10.1016\/j.bbr.2011.04.041_bib0115","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S0022-3565(25)09569-2","article-title":"SNC 80, a selective, nonpeptidic and systemically active opioid delta agonist","volume":"273","author":"Bilsky","year":"1995","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0120","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/S0022-3565(25)39525-X","article-title":"A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86","volume":"267","author":"Chang","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0125","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/0014-2999(95)00026-H","article-title":"Antinociceptive effects of the selective non-peptidic delta-opioid receptor agonist TAN-67 in diabetic mice","volume":"276","author":"Kamei","year":"1995","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0130","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1124\/jpet.102.036525","article-title":"Comparison of receptor mechanisms and efficacy requirements for delta-agonist-induced convulsive activity and antinociception in mice","volume":"303","author":"Broom","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0135","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1254\/jphs.FPJ04014X","article-title":"Potential anxiolytic and antidepressant-like activities of SNC80, a selective delta-opioid agonist, in behavioral models in rodents","volume":"95","author":"Saitoh","year":"2004","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0140","unstructured":"Nagase H, Tanaka T, Saitoh A, inventor; Toray Industries Inc., assignee. Therapeutics of preventive medicines for mood disorders or anxiety disorders. WO\/2002\/002117; 2002 Oct 1."},{"key":"10.1016\/j.bbr.2011.04.041_bib0145","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1038\/266730a0","article-title":"Depression: a new animal model sensitive to antidepressant treatments","volume":"266","author":"Porsolt","year":"1977","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2011.04.041_bib0150","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0165-6147(02)02017-5","article-title":"Assessing antidepressant activity in rodents: recent developments and future needs","volume":"23","author":"Cryan","year":"2002","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0155","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neuroscience.2005.06.006","article-title":"Facilitation of enkephalins-induced delta-opioid behavioral responses by chronic amisulpride treatment","volume":"135","author":"Cordonnier","year":"2005","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbr.2011.04.041_bib0160","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1254\/jphs.08149FP","article-title":"Gene expression profiling reveals complex changes in the olfactory bulbectomy model of depression after chronic treatment with antidepressants","volume":"108","author":"Takahashi","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0165","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1016\/S0022-3565(25)39544-3","article-title":"Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice","volume":"267","author":"Comer","year":"1993","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0170","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0022-3565(25)22505-8","article-title":"Behavioral effects of the systemically active delta opioid agonist BW373U86 in rhesus monkeys","volume":"270","author":"Negus","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0175","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00213-002-1179-y","article-title":"Convulsant activity of a non-peptidic delta-opioid receptor agonist is not required for its antidepressant-like effects in Sprague-Dawley rats","volume":"164","author":"Broom","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2011.04.041_bib0180","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1124\/jpet.103.061242","article-title":"Delta-opioid agonists: differential efficacy and potency of SNC80, its 3-OH (SNC86) and 3-desoxy (SNC162) derivatives in Sprague-Dawley rats","volume":"309","author":"Jutkiewicz","year":"2004","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0185","doi-asserted-by":"crossref","first-page":"6302","DOI":"10.1016\/j.bmcl.2010.08.083","article-title":"Design and synthesis of KNT-127, a delta-opioid receptor agonist effective by systemic administration","volume":"20","author":"Nagase","year":"2010","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/j.bbr.2011.04.041_bib0190","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1016\/j.bmcl.2009.03.099","article-title":"Design and synthesis of novel delta opioid receptor agonists and their pharmacologies","volume":"19","author":"Nagase","year":"2009","journal-title":"Bioorg Med Chem Lett"},{"issue":"February","key":"10.1016\/j.bbr.2011.04.041_bib0195","article-title":"Genetic ablation of delta opioid receptors in nociceptive sensory neurons increases chronic pain and abolishes opioid analgesia","author":"Gaveriaux-Ruff","year":"2011","journal-title":"Pain"},{"key":"10.1016\/j.bbr.2011.04.041_bib0200","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1016\/S0024-3205(99)00417-8","article-title":"Potent antinociceptive effects of TRK-820, a novel kappa-opioid receptor agonist","volume":"65","author":"Endoh","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0205","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0304-3959(87)90088-1","article-title":"The formalin test in mice: dissociation between inflammatory and non-inflammatory pain","volume":"30","author":"Hunskaar","year":"1987","journal-title":"Pain"},{"key":"10.1016\/j.bbr.2011.04.041_bib0210","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0014-2999(97)00085-X","article-title":"Supraspinal delta 1-opioid receptor-mediated antinociceptive properties of (\u2212)-TAN-67 in diabetic mice","volume":"322","author":"Kamei","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1124\/jpet.103.055590","article-title":"Evidence for a selective role of the delta-opioid agonist [8R-(4bS*,8aalpha,8abeta,12bbeta)]7,10-dimethyl-1-methoxy-11-(2-methylpropyl)oxycarbonyl 5,6,7,8,12,12b-hexahydro-(9H)-4,8-methanobenzofuro[3,2-e]pyrrolo[2,3-g]isoquinoline hydrochloride (SB-235863) in blocking hyperalgesia associated with inflammatory and neuropathic pain responses","volume":"307","author":"Petrillo","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0220","doi-asserted-by":"crossref","first-page":"5893","DOI":"10.1021\/jm8008986","article-title":"Potent, orally bioavailable delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-4-(5-hydroxyspiro[chromene-2,4\u2032-piperidine]-4-yl)benzamide (ADL5859)","volume":"51","author":"Le Bourdonnec","year":"2008","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbr.2011.04.041_bib0225","doi-asserted-by":"crossref","first-page":"5685","DOI":"10.1021\/jm900773n","article-title":"Spirocyclic delta opioid receptor agonists for the treatment of pain: discovery of N,N-diethyl-3-hydroxy-4-(spiro[chromene-2,4\u2032-piperidine]-4-yl) benzamide (ADL5747)","volume":"52","author":"Le Bourdonnec","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbr.2011.04.041_bib0230","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1124\/jpet.108.146969","article-title":"JNJ-20788560 [9-(8-azabicyclo[3.2.1]oct-3-ylidene)-9H-xanthene-3-carboxylic acid diethylamide], a selective delta opioid receptor agonist, is a potent and efficacious antihyperalgesic agent that does not produce respiratory depression, pharmacologic tolerance, or physical dependence","volume":"329","author":"Codd","year":"2009","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0235","doi-asserted-by":"crossref","DOI":"10.1124\/jpet.111.179432","article-title":"Preclinical pharmacology of AZD2327 \u2013 a highly selective agonist of the d opioid receptor","author":"Hudzik","year":"2011","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.bbr.2011.04.041_bib0240","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.neubiorev.2005.03.008","article-title":"Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test","volume":"29","author":"Cryan","year":"2005","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.bbr.2011.04.041_bib0245","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2011.04.041_bib0250","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","article-title":"Inflammatory pain is enhanced in delta opioid receptor-knockout mice","volume":"27","author":"Gav\u00e9riaux-Ruff","year":"2008","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0255","doi-asserted-by":"crossref","first-page":"PL331","DOI":"10.1016\/0024-3205(96)00175-0","article-title":"In vivo labeling of delta opioid receptors in mouse brain by [3H]benzylidenenaltrexone, a ligand selective for the delta 1 subtype","volume":"58","author":"Lever","year":"1996","journal-title":"Life Sci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0260","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0014-2999(98)00268-4","article-title":"Selective in vivo binding of [3H]naltriben to delta-opioid receptors in mouse brain","volume":"350","author":"Lever","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0265","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S0026-895X(25)09932-8","article-title":"Pharmacological characterization of the cloned kappa-, delta-, and mu-opioid receptors","volume":"45","author":"Raynor","year":"1994","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0270","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S0006-2952(99)00404-9","article-title":"Pharmacological delta1- and delta2-opioid receptor subtypes in the human neuroblastoma cell line SK-N-BE: no evidence for distinct molecular entities","volume":"59","author":"Allouche","year":"2000","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0275","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S0014-2999(02)02241-0","article-title":"Several delta-opioid receptor ligands display no subtype selectivity to the human delta-opioid receptor","volume":"451","author":"Parkhill","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0280","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.biopsych.2009.05.019","article-title":"The delta(1) opioid receptor is a heterodimer that opposes the actions of the delta(2) receptor on alcohol intake","volume":"66","author":"Van Rijn","year":"2009","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.bbr.2011.04.041_bib0285","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S0169-328X(97)00109-5","article-title":"Detection of opioid receptor mRNA by RT-PCR reveals alternative splicing for the delta- and kappa-opioid receptors","volume":"48","author":"Gaveriaux-Ruff","year":"1997","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.bbr.2011.04.041_bib0290","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0014-5793(00)01929-3","article-title":"A delta opioid receptor lacking the third cytoplasmic loop is generated by atypical mRNA processing in human malignomas","volume":"480","author":"Mayer","year":"2000","journal-title":"FEBS Lett"},{"key":"10.1016\/j.bbr.2011.04.041_bib0295","doi-asserted-by":"crossref","first-page":"7285","DOI":"10.1523\/JNEUROSCI.18-18-07285.1998","article-title":"Activity of the delta-opioid receptor is partially reduced, whereas activity of the kappa-receptor is maintained in mice lacking the mu-receptor","volume":"18","author":"Matthes","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.bbr.2011.04.041_bib0300","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1038\/21441","article-title":"G-protein-coupled receptor heterodimerization modulates receptor function","volume":"399","author":"Jordan","year":"1999","journal-title":"Nature"},{"key":"10.1016\/j.bbr.2011.04.041_bib0305","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(03)01599-1","article-title":"Identity of the putative delta1-opioid receptor as a delta-kappa heteromer in the mouse spinal cord","volume":"467","author":"Portoghese","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.bbr.2011.04.041_bib0310","doi-asserted-by":"crossref","first-page":"13117","DOI":"10.1073\/pnas.1008382107","article-title":"Coexpression of delta- and mu-opioid receptors in nociceptive sensory neurons","volume":"107","author":"Wang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.bbr.2011.04.041_bib0315","doi-asserted-by":"crossref","first-page":"e5425","DOI":"10.1371\/journal.pone.0005425","article-title":"In vivo delta opioid receptor internalization controls behavioral effects of agonists","volume":"4","author":"Pradhan","year":"2009","journal-title":"PLoS One"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432811003512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432811003512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T12:26:44Z","timestamp":1741177604000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432811003512"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10]]},"references-count":63,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,10]]}},"alternative-id":["S0166432811003512"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2011.04.041","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2011,10]]}}}